Introduction to evidence-based imaging

Neuroimaging Clinics of North America

Volumn 13, Issue 2, 2003, Pages 157-165

  Medina, L Santiago ^a   Aguirre, Elsa ^a   Zurakowski, David ^b  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EVIDENCE BASED MEDICINE; FUNCTIONAL ANATOMY; HEALTH CARE DELIVERY; HUMAN; IMAGE QUALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 0038729396     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-5149(03)00021-2     Document Type: Review

References (23)

1. Medina LS. Study design and analysis in neuroradiology: a practical approach. AJNR Am J Neuroradiol 1999;20:1584-96.
2. Wood BP. What's the evidence? Radiology 1999;213: 635-7.
3. Kent DL, Haynor DR, Longstreith WT, Larson EB. The clinical efficacy of magnetic resonance imaging in neuroimaging. Ann Intern Med 1994;120:856-71.
4. Hulley SB, Cummings SR. Designing clinical research: an epidemiologic approach. Baltimore (MD): Williams & Wilkins; 1998. p. v-135.
5. Hennekens CH, Buring JE. Epidemiology in medicine. Boston (MA): Little, Brown; 1987. p. 23-212.
6. Donner A. Approaches to sample size estimation in the design of clinical trials: a review. Stat Med 1984;3: 199-214.
7. Medina LS, Zurakowski D. Measurement variability and confidence intervals in medicine: why should radiologists care? Radiology 2003;226:297-301.
8. Lang TA, Secic M. How to report statistics in medicine. Philadelphia (PA): American College of Physicians; 1997. p. 248-77.
9. Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. BMJ 1986;292:746-50.
10. Weinstein MC, Fineberg HV. Clinical decision analysis. Philadelphia (PA): WB Saunders; 1980. p. 75-130.
11. Sunshine JH, McNeil BJ. Rapid method for rigorous assessment of radiology imaging technologies. Radiology 1997;202:549-57.
12. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978;8:283-98.
13. Singer ME, Applegate KE. Cost-effectiveness analysis in radiology. Radiology 2001;219:611-20.
14. Doubilet P, Weinstein MC, McNeil BJ. Use and misuse of the term "cost effective" in medicine. N Engl J Med 1986;314:253-6.
15. In: Gold MR, Siegel SE, Russell LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York (NY): Oxford University Press; 1996. p. 3-311.
16. Hillemann DE, Lucas BD, Mohiuddin SM, Holmberg MJ. Cost-minimization analysis of intravenous adenosine and dipyridamole in thallous chloride T1 201 SPECT myocardial perfusion imaging. Ann Pharmacother 1997;31:974-9.
17. Hricak H, Powell CB, Yu KK, et al. Invasive cervical carcinoma: role of MR imaging in pretreatment workup cost minimization and diagnostic efficacy analysis. Radiology 1996;198:403-9.
18. White MC, Langer JC, Don S, DeBaun MR. Sensitivity and cost minimization analysis of radiology versus olive palpation for the diagnosis of hypertrophic pyloric stenosis. J Pediatr Sur 1998;33:913-7.
19. Evens RG. Diagnostic imaging in cancer care: the role of cost/benefit analysis. Cancer 1991;67(Suppl 4): 1245-52.
20. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, et al. Five hundred life-saving interventions and their cost-effectiveness. Risk Analysis 1995;15(3):369-90.
21. Eddy DM. Appropriateness of cervical cancer screening. Gynecol Oncol 1981;12(2 Part 2):S168-87.
22. England WL, Halls JJ, Hunt VB. Strategies for screening for colorectal carcinoma. Med Decis Making 1989;9:3-13.
23. Yin D, Forman HP, Langlotz CP. Evaluating health services: the importance of patients' preference and quality of life. AJR Am J Roentgenol 1995;165:1323-8.